| Alcohol use and co-use of other substances among pregnant females aged 12–44 years—United States, 2015–2018 LJ England MMWR. Morbidity and Mortality Weekly Report 69, 2020 | 80 | 2020 |
| Antibiotics dispensed to privately insured pregnant women with urinary tract infections—United States, 2014 EC Ailes MMWR. Morbidity and mortality weekly report 67, 2018 | 49 | 2018 |
| Use of benzodiazepine medications during pregnancy and potential risk for birth defects, National Birth Defects Prevention Study, 1997–2011 SC Tinker, J Reefhuis, RH Bitsko, SM Gilboa, AA Mitchell, EL Tran, ... Birth defects research 111 (10), 613-620, 2019 | 32 | 2019 |
| Safety of antimicrobials during pregnancy: a systematic review of antimicrobials considered for treatment and postexposure prophylaxis of plague PA Yu, EL Tran, CM Parker, HJ Kim, EL Yee, PW Smith, Z Russell, ... Clinical Infectious Diseases 70 (Supplement_1), S37-S50, 2020 | 15 | 2020 |
| National Birth Defects Prevention Study. Use of benzodiazepine medications during pregnancy and potential risk for birth defects, National Birth Defects Prevention Study, 1997-2011 SC Tinker, J Reefhuis, RH Bitsko, SM Gilboa, AA Mitchell, EL Tran, ... Birth Defects Res 111 (10), 613-620, 2019 | 11 | 2019 |
| Systematic review: Polysubstance prevalence estimates reported during pregnancy, US, 2009–2020 EL Tran, LJ England, Y Park, CH Denny, SY Kim Maternal and child health journal 27 (3), 426-458, 2023 | 9 | 2023 |
| Receipt of American Heart Association–recommended preconception health care among privately insured women with congenital heart defects, 2007–2013 SL Farr, KF Downing, EC Ailes, M Gurvitz, G Koontz, EL Tran, CJ Alverson, ... Journal of the American Heart Association 8 (18), e013608, 2019 | 9 | 2019 |
| The MATernaL and Infant NetworK to understand outcomes associated with treatment of opioid use disorder during pregnancy (MAT-LINK): surveillance opportunity EL Tran, SY Kim, LJ England, C Green, EP Dang, CS Broussard, ... Journal of Women's Health 29 (12), 1491-1499, 2020 | 8 | 2020 |
| Opioid prescription claims among women aged 15–44 years—United States, 2013–2017 AD Summers, EC Ailes, MK Bohm, EL Tran, CS Broussard, MT Frey, ... Journal of opioid management 17 (2), 125, 2021 | 7 | 2021 |
| Medication for opioid use disorder during pregnancy—maternal and infant network to understand outcomes associated with use of medication for opioid use disorder during … K Miele, SY Kim, R Jones, JH Rembert, EM Wachman, H Shrestha, ... MMWR Surveillance Summaries 72 (3), 1, 2023 | 2 | 2023 |
| A field placement approach to enhance state and local capacity for opioid-related issues affecting pregnant and postpartum people and infants prenatally exposed to opioids and … MK Weber, EL Tran, CD Kroelinger, C Ellison, T Mueller, L Romero, ... Journal of Women's Health 31 (2), 145-153, 2022 | 2 | 2022 |
| Maternal cyclobenzaprine exposure and risk of birth defects in the National Birth Defects Prevention Study (1997–2011) and Birth Defects Study to Evaluate Pregnancy exposureS … SC Fisher, MM Howley, EL Tran, EC Ailes, EA Papadopoulos, ... Pharmacoepidemiology and Drug Safety 32 (8), 855-862, 2023 | 1 | 2023 |
| Modernizing EHRs for Maternal Health Patient-Centered Outcomes Research V Grigorescu, N Chakhtoura, E Tran, S Williams, R Abbey 2022 Annual Research Meeting, 2022 | | 2022 |
| Maternal Cyclobenzaprine Exposure and Risk of Birth Defects in the National Birth Defects Prevention Study (1997-2011) and Birth Defects Study to Evaluate Pregnancy Exposures … SC Fisher, MM Howley, EL Tran, EC Ailes, EA Papadopoulos, ... BIRTH DEFECTS RESEARCH 114 (9), 392-392, 2022 | | 2022 |
| Alcohol Use and Co-Use of Other Substances Among Pregnant Females Aged 12-44 Years-United States, 2015-2018 (vol 69, pg 1009, 2020) LJ England, C Bennett, CH Denny, MA Honein, SM Gilboa, SY Kim, ... MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT 69 (34), 1184-1184, 2020 | | 2020 |
